Rockville, MD — The acquisition of BioCheck expands OriGene’s IVD portfolio and capabilities for future product development, leveraging its current leading Chinese diagnostics channels. China’s IVD market is among the fastest growing in the world, and from recent annual growth rates, it is predicted to be the world’s second largest IVD market by 2017. The […]
SAN DIEGO, CA –– Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services worldwide, today announced it has added the Illumina MiSeqDx to its fleet of next-generation sequencing systems. Designed and validated for the clinical market, the benchtop sequencing system will optimize the company’s ability to develop […]
BREA, CALIF. – With a strong commitment to advancing innovation in the clinical laboratory, PCL Alverno Clinical Laboratories awarded Beckman Coulter Diagnostics a new installation agreement. Processing more than 23 million tests per year, and dedicated to improving the quality of patient care, PCL Alverno was recently named a leader in innovation in Indiana and […]
SALT LAKE CITY –BioFire Diagnostics, LLC today announced that it has submitted the FilmArray Gastrointestinal (GI) Panel to the U.S. Food and Drug Administration (FDA) for 510(k) clearance. The comprehensive FilmArray GI Panel tests for over 20 common bacteria, viruses and parasites that cause infectious diarrhea. The submission of the FilmArray GI Panel comes after […]
NEW YORK—Enzo Biochem Inc. (NYSE:ENZ) today announced that its Enzo Clinical Labs subsidiary and Massachusetts-based Nuclea Biotechnologies, Inc. have entered into a non-exclusive distribution agreement to market Nuclea’s non-invasive HER-2/neu serum test, a key assay in the monitoring of metastatic breast cancer. This blood test facilitates the monitoring and treatment decisions of women with metastatic […]
ST. LOUIS, Mo. and LEXINGTON, Mass. – Appistry, a leading provider of high-performance computing and analytics solutions for next-generation medicine, and N-of-One, the leading provider of molecular interpretation and therapeutic strategies for personalized medicine in cancer care, today announced a partnership to jointly provide genetic sequencing data analysis and molecular interpretation services. This partnership will […]
Baltimore, MD -– BD Diagnostics, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that the company has achieved CE/IVD marking for the BD OnclarityTM HPV Assay on the new BD ViperTM LT System. The BD Onclarity HPV Assay targets E6/E7 DNA oncogenes and is designed to provide […]
Baltimore, MD -– BD Diagnostics, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that the company has achieved CE/IVD marking for the BD OnclarityTM HPV Assay on the new BD ViperTM LT System. The BD Onclarity HPV Assay targets E6/E7 DNA oncogenes and is designed to provide […]
GLOSTRUP, Denmark –Dako, an Agilent Technologies company and worldwide provider of cancer diagnostics, today announced positive findings in an independent French multicenter study on the performance of Dako’s HER2 IQFISH pharmDx™. The Toulouse, France, breast cancer group led by Magali Lacroix-Triki, has published a peer-reviewed publication in the Journal of Histopathology(1) that supports the use […]
GLOSTRUP, Denmark. Dako, an Agilent Technologies company and worldwide provider of cancer diagnostics, today announced a new project with Amgen to develop a molecular diagnostic test using Dako’s IQFISH hybridization buffer. “We are pleased to continue our work with Amgen, particularly within the molecular arena,” said Jacob Thaysen, vice president and general manager for Agilent’s […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
